Neuropeptide Therapy of Recent Onset Type 1 Diabetes

Clinical trial NCT02820558 · UNKNOWN

Trial details

NCT number: NCT02820558
Sponsor: Vanilloid Genetics Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1

Start date: 2016-05-01
Primary completion: 2022-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.